Trials / Completed
CompletedNCT01271764
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Tumor invasion and metastasis are the major causes of cancer-related death. Some studies have found that histone methyltransferases, such as EZH2, specifically affect metastasis in breast, gastric and prostate cancer. The functional roles of other members of the HMT family such as G9a in cancer remain obscure. Therefore, the investigators will investigate whether G9a have a role in recurrence/metastasis of endometrial cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no drug | The role of G9a protein in patients with endometrial cancer |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-07-01
- Completion
- 2012-09-01
- First posted
- 2011-01-07
- Last updated
- 2012-09-26
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01271764. Inclusion in this directory is not an endorsement.